Document is current
Any future updates will be listed below
-
Authors
Wilkinson, Samuel T.
Rhee, Taeho Greg
Tsai, Jack
-
Funding
Funding for this research was provided by:
U.S. Department of Veterans Affairs
- License Information
-
More Information
Article History
Accepted: 22 August 2021
First Online: 1 September 2021
Declarations
:
: The study procedures for this secondary analysis of restricted data were approved by the Institutional Review Board (HIC #2000022916) at Yale School of Medicine. Informed consent was not deemed necessary by the IRB.
: Dr. Wilkinson has received contract funding from Janssen, Sage Therapeutics, and Oui Therapeutics for the conduct of clinical trials administered through Yale University. He has received consulting fees from Janssen, Oui Therapeutics, Sage Therapeutics, and Biohaven Pharmaceuticals. The other authors have no conflicts to disclose.
